RESUMEN
BACKGROUND: It is unknown whether the degree of high-sensitivity troponin T (hsTropT) elevation in patients with suspected myocardial infarction without obstructive coronary arteries (MINOCA) presentations can help predict the likelihood of an abnormal cardiac magnetic resonance (CMR) scan. In this study we describe the diagnostic utility of CMR in patients with MINOCA and assesses the effect of peak hsTropT levels at presentation on CMR diagnostic yield. METHODS: Records of consecutive patients (n = 1407) referred for CMR at a tertiary referral hospital between January 2016 and September 2021 were reviewed. A total of 70 patients met the criteria of MINOCA including ischemic chest pain, elevated peak hsTropT, and nonobstructive coronary artery disease (< 50% stenosis). The peak hsTropT levels within 72 hours of admission were identified. CMR images were generated using a 3.0 T Siemens scanner. Predictors of having an abnormal CMR were evaluated. RESULTS: CMR established a diagnosis in 71% (n = 50) of patients, with the most common CMR diagnosis being myopericarditis (n = 27; 39%). Time to CMR was an independent predictor of a normal CMR scan (odds ratio, 0.98; 95% confidence interval, 0.97-0.999). Peak hsTropT had a high diagnostic accuracy for identifying patients with an abnormal CMR scan (area under the receiver operator characteristic curve, 0.81; P < 0.001). The optimal hsTropT cutoff was 166 ng/L, with 72% sensitivity and specificity. A troponin value ≥ 166 ng/L was independently predictive of an abnormal CMR scan (odds ratio, 4.76; 95% confidence interval, 1.32-17.11). CONCLUSIONS: HsTropT and early CMR imaging are independently predictive of an abnormal CMR scan in patients with MINOCA. Additionally, the use of a hsTropT cutoff provides incremental predictive value to clinical parameters and time to CMR scanning in determining an abnormal scan.
Asunto(s)
Enfermedad de la Arteria Coronaria , Infarto del Miocardio , Humanos , Troponina T , MINOCA , Angiografía Coronaria/métodos , Imagen por Resonancia MagnéticaRESUMEN
INTRODUCTION: We report a series of patients who had computed tomography (CT) of their brains which showed an uncommon artefact caused by excess air bubbles in the cooling oil around the X-ray tube. METHODS: In November and December 2015, it was recognised that artefacts appearing on CT brain images acquired at our department were caused by a scanner fault. The test images were reviewed and the service engineer for the CT scanner was questioned about the artefact cause. A retrospective audit was then performed of images acquired on the CT scanner from December 2015 back to the date that the CT scanner was last serviced in September 2015 to identify any other scans affected by the artefact. RESULTS: Seven patients were identified whose CT brain scans showed the artefact. The artefact manifested in the form of an ill-defined low density area in varying locations. The artefact also appeared on CT phantom test images. It was discovered to be caused by the presence of excess air bubbles within the cooling oil of the X-ray tube. The fault was then rectified. CONCLUSIONS: The artefact described may not be easily recognised and could lead to misinterpretation and unnecessary investigation. We aim to promote awareness of this artefact and to reinforce the importance of frequent quality control testing of CT systems.
Asunto(s)
Aire , Artefactos , Neuroimagen/instrumentación , Aceites , Tomógrafos Computarizados por Rayos X , Humanos , Fantasmas de Imagen , Estudios RetrospectivosAsunto(s)
Fístula Arteriovenosa/complicaciones , Infarto del Miocardio/complicaciones , Vena Cava Superior/anomalías , Anciano , Oclusión Coronaria/complicaciones , Cianosis/etiología , Disnea/etiología , Ecocardiografía , Atrios Cardíacos/anomalías , Humanos , Hipoxia/etiología , Masculino , Tomografía Computarizada por Rayos XRESUMEN
Developments in magnetic resonance imaging (MRI) techniques have expanded the role of MRI in evaluating the liver. Although a single optimized protocol for standard hepatic MRI examination has not been established or agreed on, key elements to a successful exam are generally accepted. In determining the "best" protocol, one must first understand the numerous pulse sequences and contrast agents available to the technologist and how each contributes to the final interpretation by the radiologist. This article will attempt to review the most commonly used pulse sequences for imaging the liver, with comment on their uses, advantages, and limitations. The spectrum of contrast agents available for use in liver MRI will also be discussed.
RESUMEN
BACKGROUND: The use of saphenous vein grafts (SVG) in coronary artery bypass surgery is established but little is known of SVG remodeling during the first year in vivo. METHODS AND RESULTS: The feasibility of measuring total vessel diameter (lumen plus wall), lumen diameter, and wall thickness by a novel computed tomography (CT) method was established in phantom model tubes (r=0.98 for lumen diameter and r=0.98 for wall thickness) and in an initial clinical study of 14 patients correlating CT and intravascular ultrasound measurements of SVG (r=0.88 for total vessel diameter, r=0.85 for lumen diameter and r=0.89 for wall thickness). In a separate group of 42 patients (aged 66+/-10 years; 36 male, 6 female) undergoing coronary artery bypass grafting, SVG total vessel diameter, lumen diameter, and wall thickness were determined prospectively with multi-slice CT angiography at 1 and 12 months postoperatively. Mean total vessel diameter decreased from 5.95+/-0.83 mm to 5.39+/-0.87 mm, P<0.001 (range, -39% to +8% change). Twenty-six patients (62%) had a decrease of SVG vessel diameter (negative remodeling) >5%. Mean lumen diameter decreased from 3.69+/-0.66 mm to 3.36+/-0.68 mm, P<0.001, (range, -40 to +11% change). Surprisingly, mean wall thickness decreased from 1.14+/-0.27 mm to 1.01+/-0.21 mm (P<0.001; range, -48 to +33% change). CONCLUSIONS: Lumen loss in SVG between postoperative months 1 and 12 is predominantly caused by negative remodeling of the whole vessel rather than to changes in wall thickness. Therapies targeting negative remodeling may be required for optimal maintenance of SVG lumen in the first postoperative year.
Asunto(s)
Puente de Arteria Coronaria/métodos , Reestenosis Coronaria/etiología , Oclusión de Injerto Vascular/etiología , Vena Safena/trasplante , Antagonistas Adrenérgicos beta/farmacología , Anciano , Estudios de Cohortes , Puente de Arteria Coronaria/estadística & datos numéricos , Reestenosis Coronaria/diagnóstico por imagen , Reestenosis Coronaria/epidemiología , Reestenosis Coronaria/patología , Reestenosis Coronaria/fisiopatología , Estudios de Factibilidad , Femenino , Estudios de Seguimiento , Oclusión de Injerto Vascular/diagnóstico por imagen , Oclusión de Injerto Vascular/epidemiología , Oclusión de Injerto Vascular/patología , Oclusión de Injerto Vascular/fisiopatología , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Masculino , Metoprolol/farmacología , Persona de Mediana Edad , Fantasmas de Imagen , Periodo Posoperatorio , Vena Safena/diagnóstico por imagen , Vena Safena/patología , Método Simple Ciego , Tomografía Computarizada por Rayos X , Trasplante Heterólogo , Ultrasonografía IntervencionalRESUMEN
UNLABELLED: Transient ischemic dilation of the left ventricle found on SPECT myocardial perfusion imaging (MPI) is an accepted marker of severe and extensive coronary artery disease (CAD) and poor prognosis. The influence of other clinical variables on the incidence of transient ischemic dilation is less certain. The aim of this study was to investigate clinical factors that may influence the incidence of transient ischemic dilation. In particular, we looked at factors that may independently affect subendocardial perfusion, such as left ventricular hypertrophy (LVH) and diabetes. METHODS: MPI studies of 103 consecutive patients who had undergone recent coronary angiography (< or =6 mo) and transthoracic echocardiography within a year of stress electrocardiography-gated MPI were retrospectively analyzed. Transient ischemic dilation was assessed quantitatively using a software program. A ratio cutoff of > or =1.22 was considered to represent transient ischemic dilation. Summed stress score and summed difference score (ischemia score) were determined using the standard 17-segment 5-point scoring system to quantify myocardial ischemia. LVH was defined as a left ventricular wall thickness of >11 mm on M-mode echocardiography. Severe CAD was defined as severe stenosis (> or =90%) of either the left anterior descending artery or both the right coronary and lateral circumflex arteries. RESULTS: Nineteen (18%) of the 103 patients had transient ischemic dilation, 19 (18%) had LVH, and 23 (22%) were diabetic. A high percentage had severe CAD (46/103 [45%]), whereas 57 of 103 (55%) had less severe CAD (30/103 [29%]) or nonsignificant CAD (26/103 [25%]). Severe CAD (P < 0.001), diabetes (P < 0.0001), LVH (P < 0.003), and the ischemia score (P < 0.023) were independent predictors of transient ischemic dilation by multivariate logistic regression. In patients with severe CAD, the effect of LVH on the incidence of transient ischemic dilation was additive, increasing the incidence from 21% (8/38) without LVH to 75% (6/8) with LVH (P < 0.006). Likewise, with severe CAD, the incidence of transient ischemic dilation rose from 21% (7/33) in patients without diabetes to 54% (7/13) in those with diabetes (P < 0.04). CONCLUSION: The presence of transient ischemic dilation on myocardial perfusion SPECT is associated with the presence of severe CAD, but this association is modified by the presence of LVH and diabetes.